Platelet-derived Factors for Treatment of Muscular Lesions

IRCCS Policlinico S. Matteo

Status and phase: Completed; Phase 2

Conditions: Muscle Lesions

Treatments: Biological: platelet-derived repairing factors

Study type: Interventional

Funder types: Other

Identifiers

NCT01381770

plt-msl001

Details and patient eligibility

About

The purpose of this study is to demonstrate that platelet-derived repairing factors are effective and safe in the treatment of muscular lesion grade 2 or 3, a Phase II, open-label, single arm, single centre has been designed. Sample size will be 25.

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age > 18 years old
• if woman, no pregnancy ongoing
• muscular lesion grade 2 or 3 in a lower limb muscular group

Exclusion criteria

• no hematological conditions
• no anticoagulation in the two preceding weeks

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

Platelet-derived repairing factors

Experimental group

Treatment:

Biological: platelet-derived repairing factors